Stay updated on LA CAB+RPV Q2M Clinical Trial
Sign up to get notified when there's something new on the LA CAB+RPV Q2M Clinical Trial page.

Latest updates to the LA CAB+RPV Q2M Clinical Trial page
- Check3 days agoChange DetectedThe update shows a redesigned layout and navigation for the study page, while core study details such as the title, identifiers, and outcomes remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check10 days agoNo Change Detected
- Check32 days agoChange Detected- Added a government operating status notice and a link to official sources for NIH Clinical Center status. - Updated version to v3.2.0 and removed reference to v3.1.0.SummaryDifference0.9%

- Check39 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0.SummaryDifference0.0%

- Check54 days agoChange DetectedUpdated page revision from v3.0.1 to v3.0.2 and removed the Back to Top link. No substantive changes to core content, pricing, or availability are apparent.SummaryDifference0.1%

- Check61 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.1%

- Check68 days agoChange DetectedThe web page has updated its facility name and location details, including specific addresses in Washington D.C. and Ft. Pierce, Florida, while also adding new drug information related to Dolutegravir and a reference to a recent publication on HIV treatment advancements.SummaryDifference0.8%

Stay in the know with updates to LA CAB+RPV Q2M Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LA CAB+RPV Q2M Clinical Trial page.